OnKure Therapeutics price target lowered to $34 from $40 at H.C. Wainwright
H.C. Wainwright lowered the firm’s price target on OnKure Therapeutics (OKUR) to $34 from $40 and keeps a Buy rating on the shares. The firm ...
Yahoo Finance5d
OnKure Therapeutics, Inc. (OKUR)
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the... BOULDER, Colo., March 04, 2025 (GLOBE NEWSWIRE) -- OnKure Therapeutics, Inc ...
Yahoo Finance4d
Relay Therapeutics, Inc. (RLAY)
After hours: 19 March at 17:43:00 GMT-4 Loading Chart for RLAY ...